Tryptophan is an essential amino acid that is the sole precursor of serotonin (5-hydroxytryptamine, 5-HT) — the neurotransmitter that regulates mood, anxiety, sleep, appetite, pain perception, and a broad range of other physiological functions in the human brain and peripheral nervous system. Unlike other neurotransmitters that can be synthesised from multiple precursors, serotonin is synthesised exclusively from tryptophan through a two-step enzymatic pathway: tryptophan hydroxylase (TPH) converts tryptophan to 5-hydroxytryptophan (5-HTP), and aromatic L-amino acid decarboxylase (AAAD) converts 5-HTP to serotonin. This exclusive dependence of serotonin synthesis on tryptophan availability is the physiological basis of the well-documented relationship between tryptophan depletion and depressed mood — when tryptophan levels fall (as during dietary restriction, as during the catabolism of tryptophan by the indoleamine 2,3-dioxygenase enzyme that is activated by interferon-alpha and other inflammatory cytokines), serotonin synthesis in the brain decreases, and mood declines in proportion to the decline in serotonin synthesis. This relationship is one of the most well-established in all of neuroscience and is the foundation of the serotonin hypothesis of depression.
The Serotonin System
The serotonergic neurons of the brain are located in the raphe nuclei of the brainstem and project to virtually every region of the brain and spinal cord, providing the most diffuse neurotransmitter innervation of any neurotransmitter system in the brain. This diffuse innervation pattern is consistent with the broad range of functions that serotonin regulates — including mood (the serotonergic projections to the prefrontal cortex and limbic system are the primary substrates of the antidepressant effect), anxiety (the serotonergic inhibition of the amygdala is the primary mechanism of the anti-anxiety effect), sleep (the serotonergic inhibition of the arousal centres of the brainstem is the primary mechanism of sleep induction), appetite (serotonin suppresses appetite through actions on the hypothalamus), pain perception (serotonergic inhibition of the dorsal horn of the spinal cord is an important mechanism of descending pain control), and the regulation of the HPA axis (serotonergic stimulation of the paraventricular nucleus of the hypothalamus regulates the cortisol response to stress). The breadth of this serotonergic innervation explains why drugs that increase serotonergic neurotransmission (the SSRIs, SNRIs, MAOIs, TCAs) have such broad and diverse clinical effects across mood, anxiety, sleep, appetite, and pain disorders.
The serotonin receptors are a family of 14 distinct receptor subtypes (5-HT1A through 5-HT7, with multiple subtypes within each class) that are located on pre- and post-synaptic neurons and on non-neuronal cells throughout the brain and body. The diversity of serotonin receptor subtypes is one of the primary reasons why serotonergic drugs have such complex and varied effects — the SSRIs increase synaptic serotonin levels globally, but the downstream effects depend on the specific receptor subtypes that are activated in specific brain regions, which in turn depends on the baseline activity of the serotonergic system, the prior history of the receptor systems, and the genetic polymorphisms that determine individual differences in serotonin receptor and transporter function. This receptor diversity is also why targeted serotonin receptor agonists and antagonists (such as the 5-HT1A partial agonists used for anxiety, the 5-HT3 antagonists used for nausea, and the 5-HT4 agonists used for gastrointestinal motility) have more specific and predictable effects than the globally acting SSRIs.
Tryptophan Supplementation and Depression
The clinical evidence for tryptophan supplementation in depression is moderate and consistent. A meta-analysis of 10 double-blind RCTs in patients with major depressive disorder found that tryptophan supplementation at 2-4g daily (as tryptophan or as 5-HTP, the intermediate in serotonin synthesis) significantly reduced depression severity compared to placebo, with an effect size that was comparable to the effect size of the SSRIs in similar populations. Studies comparing tryptophan supplementation directly to SSRI treatment have found comparable efficacy between tryptophan and fluoxetine (Prozac) in mild-to-moderate depression — suggesting that tryptophan may be a useful alternative to the SSRIs for patients who cannot tolerate or do not respond to conventional SSRI therapy. The combination of tryptophan with an SSRI should be avoided due to the risk of serotonin syndrome (a potentially life-threatening condition caused by excessive serotonergic activity).
Practical Application
For general mood and serotonin support, the evidence-based dose is 500-1,000mg of tryptophan daily (as L-tryptophan or as 5-HTP, the intermediate in serotonin synthesis that is more directly converted to serotonin and is less susceptible to peripheral metabolism). Tryptophan and 5-HTP should always be taken with a carbohydrate snack or meal (the insulin response to carbohydrate intake facilitates the uptake of tryptophan and 5-HTP into the brain by reducing blood levels of the competing large neutral amino acids) and should not be taken with protein (which competes with tryptophan for the same amino acid transporter and reduces tryptophan uptake into the brain). The primary clinical indications for tryptophan or 5-HTP supplementation are mild-to-moderate depression (particularly atypical depression with prominent fatigue and hyperphagia), mild anxiety, and sleep onset insomnia. For comprehensive mood support, tryptophan or 5-HTP pairs well with omega-3 fatty acids (which support serotonin receptor function and membrane fluidity), vitamin D (which regulates the conversion of tryptophan to serotonin in the brain), and magnesium (for stress management and sleep support).
Leave a Reply